Items where Author is "Diehl, Volker"

Yes

Engert, Andreas and Josting, Andreas and Haverkamp, Heinz and Villalobos, Matthias and Lohri, Andreas and Sökler, Martin and Zijlstra, Josée and Sturm, Isrid and Topp, Max S. and Rank, Andreas and Zenz, Thorsten and Vogelhuber, Martin and Nogova, Lucia and Borchmann, Peter and Fuchs, Michael and Flechtner, Hans-Henning and Diehl, Volker. (2010) Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma : results of the randomized placebo-controlled GHSG HD15EPO trial. Journal of clinical oncology, Vol. 28, H. 13. pp. 2239-2245.

Engert, Andreas and Plütschow, Annette and Eich, Hans Theodor and Lohri, Andreas and Dörken, Bernd and Borchmann, Peter and Berger, Bernhard and Greil, Richard and Willborn, Kay C. and Wilhelm, Martin and Debus, Jürgen and Eble, Michael J. and Sökler, Martin and Ho, Antony and Rank, Andreas and Ganser, Arnold and Trümper, Lorenz and Bokemeyer, Carsten and Kirchner, Hartmut and Schubert, Jörg and Král, Zdenek and Fuchs, Michael and Müller-Hermelink, Hans-Konrad and Müller, Rolf-Peter and Diehl, Volker. (2010) Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. The New England journal of medicine, Vol. 363, H. 7. pp. 640-652.

Engert, Andreas and Diehl, Volker and Franklin, Jeremy and Lohri, Andreas and Dörken, Bernd and Ludwig, Wolf-Dieter and Koch, Peter and Hänel, Mathias and Pfreundschuh, Michael and Wilhelm, Martin and Trümper, Lorenz and Aulitzky, Walter-Erich and Bentz, Martin and Rummel, Mathias and Sezer, Orhan and Müller-Hermelink, Hans-Konrad and Hasenclever, Dirk and Löffler, Markus. (2009) Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma : 10 years of follow-up of the GHSG HD9 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27. pp. 4548-4554.

Kobe, Carsten and Dietlein, Markus and Franklin, Jeremy and Markova, Jana and Lohri, Andreas and Amthauer, Holger and Klutmann, Susanne and Knapp, Wolfram H. and Zijlstra, Josee M. and Bockisch, Andreas and Weckesser, Matthias and Lorenz, Reinhard and Schreckenberger, Matthias and Bares, Roland and Eich, Hans Theodor and Mueller, Rolf-Peter and Fuchs, Michael and Borchmann, Peter and Schicha, Harald and Diehl, Volker and Engert, Andreas. (2008) Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood, 112 (10). pp. 3989-3994.